Literature DB >> 15126547

Spinal volumetric bone mineral density and vertebral fractures in female patients with adrenal incidentalomas: the effects of subclinical hypercortisolism and gonadal status.

Iacopo Chiodini1, Giuseppe Guglielmi, Claudia Battista, Vincenzo Carnevale, Massimo Torlontano, Mario Cammisa, Vincenzo Trischitta, Alfredo Scillitani.   

Abstract

Although adrenal incidentalomas (AI) are not associated with clinically evident syndromes, some patients display biochemical features of subclinical hypercortisolism (SH). Previous studies indicated a negative effect of SH on bone in AI patients, but the prevalence of vertebral fractures and the roles of SH and gonadal status in volumetric bone mineral density are unknown. In 70 female AI patients and 84 controls, the prevalence of vertebral fractures and spinal bone mineral density (by quantitative computed tomography) were evaluated. Subjects were subdivided according to menopausal status into groups Pre (21 patients and 23 controls) and Post (49 patients and 61 controls); there were 14 and 35 patients without SH (SH(-)) and 7 and 14 patients with SH (SH(+)) in groups Pre and Post, respectively. The prevalence of fractures was higher in SH(+) than in controls and in SH(-) subjects in both groups Pre [SH(+), 42.9%; controls, 0% (P = 0.001); SH(-), 7.1% (P = 0.049)] and post [SH(+), 78.6%; controls, 37.7% (P = 0.006); SH(-) 42.9% (P = 0.024)]. In group Post, the mean z-score quantitative computed tomography values were lower in SH(+) patients (-0.78 +/- 0.29) than in controls (0.06 +/- 0.14; P = 0.011) and SH(-) patients (0.02 +/- 0.19; P = 0.034). Evaluation of spinal bone is indicated in female AI patients with SH.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15126547     DOI: 10.1210/jc.2003-031413

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  16 in total

Review 1.  Endogenous subclinical hypercortisolism: Diagnostic uncertainties and clinical implications.

Authors:  S Tsagarakis; D Vassiliadi; N Thalassinos
Journal:  J Endocrinol Invest       Date:  2006-05       Impact factor: 4.256

Review 2.  Adrenal steroids and the metabolic syndrome.

Authors:  Stephen P Thomson; Craig S Stump; L Romayne Kurukulasuriya; James R Sowers
Journal:  Curr Hypertens Rep       Date:  2007-12       Impact factor: 5.369

Review 3.  Endocrine incidentalomas--challenges imposed by incidentally discovered lesions.

Authors:  Dimitra A Vassiliadi; Stylianos Tsagarakis
Journal:  Nat Rev Endocrinol       Date:  2011-06-28       Impact factor: 43.330

Review 4.  Subclinical Cushing's syndrome.

Authors:  Massimo Terzolo; Giuseppe Reimondo; Silvia Bovio; Alberto Angeli
Journal:  Pituitary       Date:  2004       Impact factor: 4.107

5.  Increased salt consumption induces body water conservation and decreases fluid intake.

Authors:  Natalia Rakova; Kento Kitada; Kathrin Lerchl; Anke Dahlmann; Anna Birukov; Steffen Daub; Christoph Kopp; Tetyana Pedchenko; Yahua Zhang; Luis Beck; Bernd Johannes; Adriana Marton; Dominik N Müller; Manfred Rauh; Friedrich C Luft; Jens Titze
Journal:  J Clin Invest       Date:  2017-04-17       Impact factor: 14.808

Review 6.  Adrenocortical incidentalomas and bone: from molecular insights to clinical perspectives.

Authors:  Barbara Altieri; Giovanna Muscogiuri; Stavroula A Paschou; Andromachi Vryonidou; Silvia Della Casa; Alfredo Pontecorvi; Martin Fassnacht; Cristina L Ronchi; John Newell-Price
Journal:  Endocrine       Date:  2018-08-02       Impact factor: 3.633

7.  Role of adrenal gland scintigraphy in patients with subclinical hypercortisolism and incidentally discovered adrenal mass.

Authors:  F Donadio; V Morelli; A S Salcuni; C Eller-Vainicher; M Carletto; M Castellani; L Dellavedova; A Scillitani; P Beck-Peccoz; I Chiodini
Journal:  J Endocrinol Invest       Date:  2009-06-15       Impact factor: 4.256

8.  The Impact of Mild Autonomous Cortisol Secretion on Bone Turnover Markers.

Authors:  Shobana Athimulam; Danae Delivanis; Melinda Thomas; William F Young; Sundeep Khosla; Matthew T Drake; Irina Bancos
Journal:  J Clin Endocrinol Metab       Date:  2020-05-01       Impact factor: 5.958

Review 9.  Skeletal involvement in adult patients with endogenous hypercortisolism.

Authors:  I Chiodini; M Torlontano; V Carnevale; V Trischitta; A Scillitani
Journal:  J Endocrinol Invest       Date:  2008-03       Impact factor: 4.256

10.  Weekly clodronate treatment prevents bone loss and vertebral fractures in women with subclinical Cushing's syndrome.

Authors:  L Tauchmanova; E Guerra; R Pivonello; M C De Martino; M De Leo; F Caggiano; G Lombardi; A Colao
Journal:  J Endocrinol Invest       Date:  2009-05       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.